| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |